Fundraising Fox

Kano Therapeutics

Cambridge, US · Founded 2021 · 6 known investors

kanotherapeutics.com ↗
Biotechin /kano-therapeutics@kano_tx

Founders & leadership

AD
Ann DeWittDirector
FE
Floris EngelhardtExecutive Officer, Director
JV
John VroomDirector

Investors · 6

Fifty YearsSan Francisco · $250K – $2M
Launchpad Venture GroupBoston · $8M – $10M
MetaplanetTallinn · $500K – $10M
The Engine VenturesCambridge
Vsquared VenturesMünchen
ZAKA VCSan Francisco

Reported raises · per SEC filings

Form D private placements
▶$5MraisedMay 2024 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ann DeWittDirector
  • Floris EngelhardtExecutive Officer, Director
  • John VroomDirector
Offering amount
$5M
Amount sold
$5M
First sale
May 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.